Profound Medical Corp. (PROF) Tops Q3 EPS by 8c

Profound Medical Corp. (NASDAQ: PROF) reported Q3 EPS of ($0.26), $0.08 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.17 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble